During this MIPS Roundtable, we will host Dr. Carina Mari Aparici, a MIPS Faculty and Nuclear Medicine physician in the Department of Radiology. Dr. Aparici is also the Director of the Targeted Radionuclide Therapy Program at Stanford. She will present an overview of Thera(g)nostics, our program at Stanford and the present clinical status. She hopes to help link the clinical and pre-clinical Theranostic arenas within our institution, and encourage collaborations to move our own promising molecules from bench to bed-side. 

Together with MIPS we have started a new Theranostics Interest Group, with the goal of bringing together scientists, physicians, physician-scientists, and anyone who is interested in this research area to join us in brainstorming new probes, collaborating in research projects and rapidly translating promising molecules into humans. We believe a multidisciplinary approach can help better design the path of pre-clinical and clinical experiments, select the most promising  isotopes and molecular probes, and develop a rapid transition to meet the present clinic needs in the field.